TALAPRO-1: Associação entre perda genômica de heterozigosidade no tratamento do câncer de próstata com talazoparibe

Referência

1. TALAPRO-1: Talazoparib monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with tumor DNA damage response alterations (DDRm)– Exploration of genomic loss of heterozygosity (gLOH) and potential associations with antitumor activity (https://www.abstractsonline.com/pp8/#!/10517/presentation/20169)